ArcherDX, Inc.

ArcherDX, Inc.

ArcherDX, Inc.

ArcherDX, Inc., creates catalog and custom nextgeneration sequencing (NGS) assays that are purposebuilt to identify mutations and gene fusions from clinical sample types.
Founded
2013
Raised
$150M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$55,000,000
Venture capital (Series C) - 2019
Redmile Group Boulder Ventures Perceptive Advisors +5
$60,000,000
Venture capital (Series B) - 2019
Boulder Ventures Perceptive Advisors The Peierls Foundation +2
Team Size
50+
Employees
$55,000,000 Venture capital (Series C)
Pulse 2.0

Molecular Diagnostics Company ArcherDX Raises $55 Million

FinSMEs

ArcherDX Closes $55M Series C Financing

$35,000,000 Venture capital (Series A)
FinSMEs , PE HUB , Venture Funding News

ArcherDX Closes $35M Series A Financing

Funding